These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38896298)

  • 1. Machine Learning to Predict Prostate Artery Embolization Outcomes.
    Vigneswaran G; Doshi N; Maclean D; Bryant T; Harris M; Hacking N; Farrahi K; Niranjan M; Modi S
    Cardiovasc Intervent Radiol; 2024 Sep; 47(9):1248-1254. PubMed ID: 38896298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study).
    Ray AF; Powell J; Speakman MJ; Longford NT; DasGupta R; Bryant T; Modi S; Dyer J; Harris M; Carolan-Rees G; Hacking N
    BJU Int; 2018 Aug; 122(2):270-282. PubMed ID: 29645352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The First 48 Consecutive Patients with 3-Year Symptom Score Follow-Up Post-Prostate Artery Embolization (PAE) at a Single-Centre University Hospital.
    Maclean D; Harris M; Long J; Modi S; Bryant TJ; Hacking N
    Cardiovasc Intervent Radiol; 2020 Mar; 43(3):459-465. PubMed ID: 31797101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Clinical Outcome after Prostate Artery Embolization with Spherical and Nonspherical Polyvinyl Alcohol Particles in Patients with Benign Prostatic Hyperplasia.
    Bilhim T; Pisco J; Pereira JA; Costa NV; Fernandes L; Campos Pinheiro L; Duarte M; Oliveira AG
    Radiology; 2016 Oct; 281(1):289-300. PubMed ID: 27223621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Comorbidities Do Not Impact Prostate Artery Embolisation (PAE) Outcomes: Retrospective Analysis of the National UK-ROPE Registry.
    Vigneswaran G; Maclean D; Doshi N; Harris M; Bryant TJC; Hacking NC; Somani B; Modi S
    Cardiovasc Intervent Radiol; 2024 Jan; 47(1):115-120. PubMed ID: 38012342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate artery embolisation: an all-comers, single-operator experience in 159 patients with lower urinary tract symptoms, urinary retention, or haematuria with medium-term follow-up.
    Thulasidasan N; Kok HK; Elhage O; Clovis S; Popert R; Sabharwal T
    Clin Radiol; 2019 Jul; 74(7):569.e1-569.e8. PubMed ID: 30955835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of contrast-enhanced ultrasonography in detection of prostatic infarction after prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia.
    Moschouris H; Stamatiou K; Malagari K; Marmaridou K; Kladis-Kalentzis K; Kiltenis M; Papadogeorgopoulos N; Tsavari A; Manoloudaki K
    Diagn Interv Radiol; 2019 Mar; 25(2):134-143. PubMed ID: 30860077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical and Imaging Outcomes from the UK Registry of Prostate Artery Embolization (UK-ROPE) Study: Focusing on Predictors of Clinical Success.
    Hacking N; Vigneswaran G; Maclean D; Modi S; Dyer J; Harris M; Bryant T
    Cardiovasc Intervent Radiol; 2019 May; 42(5):666-676. PubMed ID: 30603967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic Artery Embolization Using 100-300-μm Trisacryl Gelatin Microspheres to Treat Lower Urinary Tract Symptoms Attributable to Benign Prostatic Hyperplasia: A Single-Center Outcomes Analysis with Medium-Term Follow-up.
    Ayyagari R; Powell T; Staib L; Chapiro J; Raja A; Bhatia S; Chai T; Schoenberger S; Devito R
    J Vasc Interv Radiol; 2020 Jan; 31(1):99-107. PubMed ID: 31771896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Clinical Outcomes of Prostatic Artery Embolization with 50-μm Plus 100-μm Polyvinyl Alcohol (PVA) Particles versus 100-μm PVA Particles Alone: A Prospective Randomized Trial.
    Wang MQ; Zhang JL; Xin HN; Yuan K; Yan J; Wang Y; Zhang GD; Fu JX
    J Vasc Interv Radiol; 2018 Dec; 29(12):1694-1702. PubMed ID: 30297313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study.
    Salem R; Hairston J; Hohlastos E; Riaz A; Kallini J; Gabr A; Ali R; Jenkins K; Karp J; Desai K; Thornburg B; Casalino D; Miller F; Hofer M; Hamoui N; Mouli S
    Urology; 2018 Oct; 120():205-210. PubMed ID: 30036614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Prostatic Artery Embolization on the Dynamic Component of Benign Prostate Hyperplasia as Assessed by Ultrasound Elastography: A Pilot Series.
    de Assis AM; Moreira AM; Carnevale FC; Marcelino ASZ; de Oliveira Cerri LM; Antunes AA; Srougi M; Cerri GG
    Cardiovasc Intervent Radiol; 2019 Jul; 42(7):1001-1007. PubMed ID: 30993369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates.
    Wang M; Guo L; Duan F; Yuan K; Zhang G; Li K; Yan J; Wang Y; Kang H
    BJU Int; 2016 Jan; 117(1):155-64. PubMed ID: 25851432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unilateral versus bilateral prostatic arterial embolization for lower urinary tract symptoms in patients with prostate enlargement.
    Bilhim T; Pisco J; Rio Tinto H; Fernandes L; Campos Pinheiro L; Duarte M; Pereira JA; Oliveira AG; O'Neill J
    Cardiovasc Intervent Radiol; 2013 Apr; 36(2):403-11. PubMed ID: 23232858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenomatous-Dominant Benign Prostatic Hyperplasia (AdBPH) as a Predictor for Clinical Success Following Prostate Artery Embolization: An Age-Matched Case-Control Study.
    Little MW; Boardman P; Macdonald AC; Taylor N; Macpherson R; Crew J; Tapping CR
    Cardiovasc Intervent Radiol; 2017 May; 40(5):682-689. PubMed ID: 28194505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of 5-Alpha-Reductase Inhibitors Use at the Time of Prostatic Artery Embolization for Treatment of Benign Prostatic Obstruction.
    Cardarelli-Leite L; de Assis AM; Moreira AM; Antunes AA; Cerri GG; Srougi M; Carnevale FC
    J Vasc Interv Radiol; 2019 Feb; 30(2):228-232. PubMed ID: 30717954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review and Meta-analysis Comparing Prostatic Artery Embolization to Gold-Standard Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia.
    Knight GM; Talwar A; Salem R; Mouli S
    Cardiovasc Intervent Radiol; 2021 Feb; 44(2):183-193. PubMed ID: 33078236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Outcome of Prostatic Artery Embolization for Patients with Benign Prostatic Hyperplasia: Single-Centre Retrospective Study in 1072 Patients Over a 10-Year Period.
    Bilhim T; Costa NV; Torres D; Pinheiro LC; Spaepen E
    Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1324-1336. PubMed ID: 35778579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome prediction of prostatic artery embolization: post hoc analysis of a randomized, open-label, non-inferiority trial.
    Abt D; Müllhaupt G; Mordasini L; Güsewell S; Markart S; Zumstein V; Kessler TM; Schmid HP; Engeler DS; Hechelhammer L
    BJU Int; 2019 Jul; 124(1):134-144. PubMed ID: 30499637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatic artery embolization in treating benign prostatic hyperplasia: a systematic review.
    Teoh JY; Chiu PK; Yee CH; Wong HM; Chan CK; Chan ES; Hou SS; Ng CF
    Int Urol Nephrol; 2017 Feb; 49(2):197-203. PubMed ID: 27896579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.